Dendritic cell uptake of human apoptotic and necrotic Neutrophils inhibits CD40, CD80, and CD86 expression and reduces allogeneic T cell responses - Relevance to systemic vasculitis

被引:55
作者
Clayton, AR [1 ]
Prue, RL [1 ]
Harper, L [1 ]
Drayson, MT [1 ]
Savage, COS [1 ]
机构
[1] Univ Birmingham, Sch Med, MRC, Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England
来源
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 08期
关键词
D O I
10.1002/art.11130
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. There is a breakdown of tolerance to neutrophil components during systemic vasculitis, which is marked by autoantibodies and T cells with specificity for proteinase 3 or myeloperoxidase, expressed on the surface of apoptotic neutrophils. This study was undertaken to investigate the effects of human apoptotic and necrotic neutrophils on human dendritic cell (DC) phenotype and ability to stimulate allogeneic T cell proliferation. Methods. DCs were generated from human peripheral blood mononuclear cells and allowed to interact with human apoptotic and necrotic neutrophils in the presence or absence of tumor necrosis factor a (TNFalpha). Effects on DC phenotype and ability to stimulate T cell proliferation were observed. Results. Immature DCs engulfed apoptotic and necrotic neutrophils, resulting in up-regulation of CD83 and class II major histocompatibility complex molecules, but down-regulation of CD40, CD80, and CD86, and a decreased ability to stimulate T cell proliferation. When TNFa was added in combination with apoptotic neutrophils, the inhibitory effects were overcome to some extent. Conclusion. Our results suggest that DC uptake of apoptotic or necrotic neutrophils alone does not shift the immune response from tolerance to autoimmunity in systemic vasculitis. However, cytokines found at sites of inflammation in vasculitis patients may act as maturation factors for DCs, and in combination with apoptotic neutrophils, may lead to an autoimmune phenotype.
引用
收藏
页码:2362 / 2374
页数:13
相关论文
共 58 条
  • [1] Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs
    Albert, ML
    Sauter, B
    Bhardwaj, N
    [J]. NATURE, 1998, 392 (6671) : 86 - 89
  • [2] Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes
    Albert, ML
    Pearce, SFA
    Francisco, LM
    Sauter, B
    Roy, P
    Silverstein, RL
    Bhardwaj, N
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (07) : 1359 - 1368
  • [3] A flow cytometric method to assess antigen-specific proliferative responses of different subpopulations of fresh and cryopreserved human peripheral blood mononuclear cells
    Allsopp, CEM
    Nicholls, SJ
    Langhorne, J
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1998, 214 (1-2) : 175 - 186
  • [4] Dendritic cells and the control of immunity
    Banchereau, J
    Steinman, RM
    [J]. NATURE, 1998, 392 (6673) : 245 - 252
  • [5] Antigen presentation by macrophages is enhanced by the uptake of necrotic, but not apoptotic, cells
    Barker, RN
    Erwig, LP
    Hill, KSK
    Devine, A
    Pearce, WP
    Rees, AJ
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 127 (02) : 220 - 225
  • [6] IL-1 beta production by human polymorphonuclear leucocytes stimulated by antineutrophil cytoplasmic autoantibodies: Relevance to systemic vasculitis
    Brooks, CJ
    King, WJ
    Radford, DJ
    Adu, D
    McGrath, M
    Savage, COS
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 106 (02) : 273 - 279
  • [7] Maturation, activation, and protection of dendritic cells induced by double-stranded RNA
    Cella, M
    Salio, M
    Sakakibara, Y
    Langen, H
    Julkunen, I
    Lanzavecchia, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05) : 821 - 829
  • [8] ANTIBODIES AGAINST GRANULE PROTEINS ACTIVATE NEUTROPHILS INVITRO
    CHARLES, LA
    CALDAS, MLR
    FALK, RJ
    TERRELL, RS
    JENNETTE, JC
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1991, 50 (06) : 539 - 546
  • [9] CSERNOK E, 1994, CLIN EXP IMMUNOL, V95, P244
  • [10] DEGUCHI Y, 1990, CLIN EXP IMMUNOL, V81, P311